Scientists have developed a noninvasive device that may not only detect melanoma cells traveling through the bloodstream, but also kill them. The device, which the investigators call Cytophone, accurately detected cancer cells in 27 […]

ELAA Technology, an Istanbul-based company, has developed a software application which is used in conjunction with a bronchoscopy unit. By providing a patient’s Computerized Tomography (CT) images and bronchoscopy camera feed, it […]

Paige, a New York-based company, is working to revolutionize the diagnosis and treatment of cancer by providing pathologists, clinicians and researchers with insights drawn from decades of data diagnosed by world experts […]

Some types of cancer cells are surrounded by a dense layer of connective tissue that acts as a barrier to cancer-killing immune cells. That poses a problem for immunotherapies, treatments that depend on interactions […]

The Food and Drug Administration (FDA) has expanded the approved use of the drug ado-trastuzumab emtansine (Kadcyla) to treat some women with HER2-positive breast cancer. Ado-trastuzumab, also called T-DM1, was initially approved by FDA more […]

Avelas Biosciences, a California-based clinical-stage oncology company, is developing AVB-620, a novel drug-device combination product for use during cancer surgery. AVB-620 works to improve surgery by detecting cancer in real-time and has […]

MiraDx, a Los Angeles-based company, is committed to discovering meaningful ways to better treat cancer in patients with mutations like and including the KRAS-variant. They are developing answers by applying their novel […]

Cellanyx, a Massachusetts-based diagnostic company, has developed proprietary live tumor cell phenotypic biomarker tests to improve cancer risk-stratification and allow informed clinical decision making. Their unique approach provides quantitative and actionable information […]